Drreddys Laboratories reported INR206.23B in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Ani Pharmaceuticals ANIP:US USD 336.68M 283K
Aurora Cannabis Inc ACB:CN CAD 556.45M 105.39M
Bayer BAYN:GR EUR 41.27B 3.25B
Canopy Growth Corp WEED:CN CAD 1.68B 9.07M
Catalent CTLT:US USD 4.7B 95M
Corcept Therapeutics CORT:US USD 473.36M 31.04M
Endo International Ordinary Shares ENDP:US USD -3925041000 726.97M
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Hikma Pharmaceutical HIK:LN USD 2.18B 277M
Horizon Pharma HZNP:US USD 5.03B 88.16M
Lannett LCI:US USD -277561000 26.5M
Lonza Group LONN:SW CHF 10.6B 586M
Novartis NOVN:VX USD 60.82B 2.1B
Pacira Pharmaceuticals PCRX:US USD 770.12M 13.49M
Phibro Animal Health PAHC:US USD 262.76M 314K
Prestige Brands PBH:US USD 1.62B 35.1M
Richter Gedeon RICHT:HB HUF 1.1T 87.5B
Supernus Pharmaceuticals SUPN:US USD 852.8M 11.36M
Teva Pharmaceutical TEVA:IT USD 8.77B 269M